PAGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient buyer. The trend is bullish, but the stock is extremely overbought (RSI_6 90) and already trading near first resistance (12.01) while pre-market is down. With no proprietary buy signal, recent analyst downgrades to Neutral, and hedge funds accelerating selling, the risk/reward for buying immediately is unattractive. Prefer to wait for a pullback toward the ~11.03 pivot (or lower) before considering entry.
Trend remains bullish: moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200) and MACD histogram is above zero and expanding (0.197), indicating upside momentum. However, RSI_6 at ~90 signals an overstretched/overbought condition where near-term downside or consolidation is more likely. Key levels: Pivot ~11.03 is the most relevant near-term support; resistance is tight overhead at R1 ~12.01 and then R2 ~12.61. With pre-market at ~11.82 (-1.50%), price is still close to resistance and vulnerable to a mean-reversion dip.
Strong technical uptrend (bullish MA stack + positive/expanding MACD).
Options market skew is strongly bullish (call-heavy OI and volume).
Latest reported quarter (2025/Q
shows continued growth: revenue +5.67% YoY, net income +4.39% YoY, EPS +13.25% YoY, gross margin improved to 53.08 (+7.93% YoY).
Pattern-based odds suggest positive bias over the next week (+5.53% median scenario) though near-term is mixed.
Extremely overbought RSI (~
increases odds of near-term pullback/consolidation—bad timing for an impatient entry.
Hedge funds are selling aggressively (selling amount up ~401% over the last quarter), which is a meaningful sentiment/positioning headwind.
Analyst tone has recently weakened via downgrades (BTG Pactual to Neutral; Santander to Neutral), reducing incremental upside catalysts.
No supportive news flow in the last week—limited event-driven catalyst to justify buying at an overbought level.
Pre-market weakness (-1.50%) while broader market is also down (S&P 500 -0.43%) can amplify downside if risk-off persists.
Latest quarter: 2025/Q3. Growth is positive but not explosive: revenue +5.67% YoY and net income +4.39% YoY, while EPS +13.25% YoY suggests improving per-share profitability. Gross margin expanded meaningfully to 53.08 (+7.93% YoY), a constructive quality signal. Overall: fundamentals support the longer-term uptrend, but they don’t override the near-term overbought setup.
Recent trend is mixed-to-slightly negative despite some target increases. On 2026-01-29 BTG Pactual downgraded to Neutral (PT $13 unchanged). On 2026-01-28 Santander downgraded to Neutral (PT $14), while UBS simultaneously reiterated Buy and raised PT to $14 (from $13). Net Wall Street view: Pros—still sees upside to the low-to-mid teens and acknowledges continued execution; Cons—multiple downgrades suggest valuation/near-term macro and comp challenges are now more in focus. Influential/politician trades: no recent congress trading data available; no politician/influential figure transactions provided. Intellectia signals: AI Stock Picker has no signal today; SwingMax has no recent signal, so there is no proprietary confirmation to chase the current level.
